Zobrazeno 1 - 10
of 47
pro vyhledávání: '"O M, Smirnova"'
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 287-294 (2024)
Lipodystrophy syndromes are a heterogeneous group of extremely rare, inherited or acquired disorders that are characterized by total or partial fat loss or its improper redistribution. The prevalence of lipodystrophies is estimated to be 1:1,000,000
Externí odkaz:
https://doaj.org/article/a3442905e229431e924cffe49492a49f
Autor:
I. V. Kononenko, O. M. Smirnova
Publikováno v:
Сахарный диабет, Vol 24, Iss 4, Pp 350-356 (2021)
Sulfonylureas are widely prescribed all over the world, mainly because of their high effectiveness. At the same time, the heterogeneity of the group is obvious, primarily in relation to the effect of drugs on the risk of developing hypoglycemic event
Externí odkaz:
https://doaj.org/article/1cedd6659ae54643b631cefee6a10323
Autor:
A S Zakharov, M S Michurova, S A Terekhin, V Yu Kalashnikov, O M Smirnova, M V Shestakova, I I Dedov
Publikováno v:
Терапевтический архив, Vol 91, Iss 12, Pp 41-46 (2019)
Type 2 diabetes mellitus (T2DM) is a serious medical and social problem leading to early disability of patients and high mortality from cardiovascular complications. The development of cardiovascular events is associated not only with the degree of c
Externí odkaz:
https://doaj.org/article/a65b6fadb4204f87b236524a6b327055
Autor:
O. M. Smirnova
Publikováno v:
Право і безпека, Vol 69, Iss 2, Pp 43-50 (2018)
On the basis of the analysis of a significant number of domestic and international theoretical and research works, where professional motivation has been researched; the author has formed own definition of the concept of the motivational profile of a
Externí odkaz:
https://doaj.org/article/e109fcd85e294da3bf02d5fb40c22c88
Autor:
I. V. Kononenko, O. M. Smirnova
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 160-165 (2018)
Insulin glargine, synthesized using recombinant DNA technology in a concentration of 100 U/ml, was the first once-daily longacting insulin analogue introduced into clinical practice in 2000. Glargin has a well-established record of efficacy and safet
Externí odkaz:
https://doaj.org/article/472ca0256956498cae1dfb379381c112
Autor:
I. V. Kononenko, O. M. Smirnova
Publikováno v:
Медицинский совет, Vol 0, Iss 3, Pp 10-17 (2016)
Despite the emergence of new antidiabetic drugs, diabetes type 2 treatment remains a relevant issue. In order to standardize and optimize medical care to patients with diabetes, global and national algorithms for type 2 diabetes treatment were develo
Externí odkaz:
https://doaj.org/article/60940f1808d3450e97c6ec214e3ae001
Autor:
O. M. Smirnova, I. V. Kononenko
Publikováno v:
Сахарный диабет, Vol 24, Iss 4, Pp 350-356 (2021)
Sulfonylureas are widely prescribed all over the world, mainly because of their high effectiveness. At the same time, the heterogeneity of the group is obvious, primarily in relation to the effect of drugs on the risk of developing hypoglycemic event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9de8339854fa0338e77beab8b945a17
https://www.dia-endojournals.ru/jour/article/view/12768
https://www.dia-endojournals.ru/jour/article/view/12768
Publikováno v:
Терапевтический архив, Vol 87, Iss 10, Pp 50-53 (2015)
Aim. To estimate the prevalence of autoantibodies pathognomonic for autoimmune diseases of connective tissue and liver in patients with type 1 diabetes mellitus (DM1) and to study their clinical features in patients positive for these indicators. Sub
Externí odkaz:
https://doaj.org/article/1ee0e7681a2e41ad9e443bfcfae122f3
Publikováno v:
Терапевтический архив, Vol 87, Iss 10, Pp 19-25 (2015)
Aim. To determine the levels of growth factors and glycation end products in patients with different forms of coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Subjects and methods. A total of 134 patients with CHD and T2DM, including
Externí odkaz:
https://doaj.org/article/f5513ace006a46b79b848d9a4c069dd1
Publikováno v:
Терапевтический архив, Vol 87, Iss 10, Pp 11-18 (2015)
Aim. To study the nature and severity of heart rate variability (HRV) and heart rate turbulence (HRT) abnormalities in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) and to assess the prevalence of cardiovascular auto
Externí odkaz:
https://doaj.org/article/970f1d16ae2a4bd7a434d3f75c9318b7